CY1112839T1 - Πεπτιδια χ-κωνοτοξινες που εχουν ενα αμινοτελικο πυρογλουταμικο οξυ - Google Patents

Πεπτιδια χ-κωνοτοξινες που εχουν ενα αμινοτελικο πυρογλουταμικο οξυ

Info

Publication number
CY1112839T1
CY1112839T1 CY20121100484T CY121100484T CY1112839T1 CY 1112839 T1 CY1112839 T1 CY 1112839T1 CY 20121100484 T CY20121100484 T CY 20121100484T CY 121100484 T CY121100484 T CY 121100484T CY 1112839 T1 CY1112839 T1 CY 1112839T1
Authority
CY
Cyprus
Prior art keywords
cys
peptides
xaa1
terminal
amino acid
Prior art date
Application number
CY20121100484T
Other languages
Greek (el)
English (en)
Inventor
Richard James Lewis
Paul Francis Alewood
Dianne Alewood
Elka Palant
Original Assignee
Xenome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenome Ltd filed Critical Xenome Ltd
Publication of CY1112839T1 publication Critical patent/CY1112839T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CY20121100484T 2002-12-02 2012-05-29 Πεπτιδια χ-κωνοτοξινες που εχουν ενα αμινοτελικο πυρογλουταμικο οξυ CY1112839T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43030602P 2002-12-02 2002-12-02
EP03812100A EP1572725B1 (en) 2002-12-02 2003-12-02 Chi-conotoxin peptides having a n-terminal pyroglutamic acid

Publications (1)

Publication Number Publication Date
CY1112839T1 true CY1112839T1 (el) 2016-02-10

Family

ID=32469446

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100484T CY1112839T1 (el) 2002-12-02 2012-05-29 Πεπτιδια χ-κωνοτοξινες που εχουν ενα αμινοτελικο πυρογλουταμικο οξυ

Country Status (13)

Country Link
US (1) US7851444B2 (enExample)
EP (1) EP1572725B1 (enExample)
JP (1) JP4565087B2 (enExample)
AT (1) ATE547424T1 (enExample)
AU (1) AU2003302609B9 (enExample)
CA (1) CA2508129C (enExample)
CY (1) CY1112839T1 (enExample)
DK (1) DK1572725T3 (enExample)
ES (1) ES2383358T3 (enExample)
NZ (1) NZ540518A (enExample)
PT (1) PT1572725E (enExample)
SI (1) SI1572725T1 (enExample)
WO (1) WO2004050690A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP627498A0 (en) * 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
WO2004050688A1 (en) * 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-II)
US8062623B2 (en) * 2004-10-15 2011-11-22 Velocys Stable, catalyzed, high temperature combustion in microchannel, integrated combustion reactors
US20070154360A1 (en) * 2005-10-13 2007-07-05 Velocys Inc. Microchannel apparatus comprising a platinum aluminide layer and chemical processes using the apparatus
CN102752032B (zh) 2011-04-22 2015-04-22 艾利森电话股份有限公司 同频负载均衡方法及其设备
EP3298086B1 (en) 2015-05-22 2020-09-09 Clemson University Research Foundation Conotoxin peptides for use in biofouling deterrence
CN119462881A (zh) * 2024-12-20 2025-02-18 深圳肽盛生物科技有限公司 μ型芋螺毒素肽及其药物组合物和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051403A (en) 1989-11-22 1991-09-24 Neurex Corporation Method of treating ischemia-related neuronal damage
ZA921292B (en) 1991-02-25 1993-08-23 Lilly Co Eli Treatment of lower urinary tract disorders.
ATE165977T1 (de) * 1991-12-30 1998-05-15 Neurex Corp Methoden zur erzeugung von analgesie und zur verstärkung von opiat-analgesie
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
WO1996040064A1 (en) 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
DK0835126T3 (da) 1995-06-27 2003-07-14 Elan Pharm Inc Sammensætninger og formuleringer til fremstilling af analgesimidler og til hamning af fremadskridende neuropatiske amertelidelser
BR9707636A (pt) 1996-02-22 1999-07-27 Neurosearch As Composto composição farmacêutica uso de um composto e processos para preparar composto e para tratar um distúrbio ou doença de um organismo animal vivo
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
CZ288739B6 (cs) 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
WO1998022126A1 (en) 1996-11-18 1998-05-28 University Of Utah Research Foundation USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
WO1998051668A1 (en) 1997-05-14 1998-11-19 Neurosearch A/S Piperidine derivatives as neurotransmitter re-uptake inhibitors
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
US6767896B1 (en) * 1999-01-29 2004-07-27 Cognetix, Inc. Conotoxin peptides
WO2000044769A1 (en) * 1999-01-29 2000-08-03 University Of Utah Research Foundation Conotoxin peptides
US20010036943A1 (en) 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
WO2002060923A2 (en) 2001-01-29 2002-08-08 Cognetix, Inc. B-superfamily conotoxins
US20030109670A1 (en) 2001-02-09 2003-06-12 University Of Utah Research Foundation Cone snail peptides
WO2004050688A1 (en) * 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-II)

Also Published As

Publication number Publication date
JP4565087B2 (ja) 2010-10-20
US20060142201A1 (en) 2006-06-29
EP1572725B1 (en) 2012-02-29
JP2006523181A (ja) 2006-10-12
PT1572725E (pt) 2012-05-28
SI1572725T1 (sl) 2012-08-31
WO2004050690A1 (en) 2004-06-17
NZ540518A (en) 2006-12-22
AU2003302609A1 (en) 2004-06-23
EP1572725A4 (en) 2008-09-24
CA2508129C (en) 2012-06-26
CA2508129A1 (en) 2004-06-17
US7851444B2 (en) 2010-12-14
EP1572725A1 (en) 2005-09-14
AU2003302609B9 (en) 2008-05-15
AU2003302609B2 (en) 2008-03-20
ATE547424T1 (de) 2012-03-15
HK1080870A1 (en) 2006-05-04
ES2383358T3 (es) 2012-06-20
DK1572725T3 (da) 2012-06-18

Similar Documents

Publication Publication Date Title
CY1112839T1 (el) Πεπτιδια χ-κωνοτοξινες που εχουν ενα αμινοτελικο πυρογλουταμικο οξυ
PH12012502372A1 (en) Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
EP0333356A3 (en) Hirudin peptides
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
PT2298278E (pt) Prevenção e redução da perda de sangue e resposta inflamatória
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
ATE278708T1 (de) Conotoxin peptid pviia
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
ATE152129T1 (de) Inhibitorvarianten der menschlichen protease vom kunitz-typ
ATE489462T1 (de) Antimikrobielles polypeptid und nutzung davon
KR930701483A (ko) Grf (쥐이알에프) 유사체 xi
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
WO2004009625A3 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES
WO2004014937A3 (en) Thrombin peptide derivatives
SI2952521T1 (en) Peptides derived from human BPLP protein, polynucleotides encoding these peptides, and antibodies directed against these peptides
JP2006523181A5 (enExample)
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
AR009805A1 (es) Peptidos que contienen cisteina
EA199900432A1 (ru) Ice-ингибирующие пептиды
NZ332946A (en) Modified forms of interleukin-5 molecules capable of antagonising of IL-5
CA2446390A1 (en) Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
AU2003260306A1 (en) Bicyclic oligopeptides
WO1999057262A3 (de) An metallionen bindendes peptid
DE60326726D1 (de) Peptide mit affinität für ein phospholipid und deren verwendung